Fagron NV (FAGR) | Stock Overview & Key Data

Fagron NV | Large-cap | Healthcare

€21.85

-0.23%

| Fagron NV Stock Comparison:

Fagron NV vs Argenx SE Fagron NV vs Solvac S.A Fagron NV vs Ion Beam Fagron NV vs Nyxoah S.A Fagron NV vs Onward Medical N.V Fagron NV vs BEL 20 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Fagron NV Performance Comparison

Loading chart data...

Fagron NV

BEL 20

View Full Price History

Stock Range

Today's Range

Low: €21.75 High: €22.05

on June 17, 2025

52 Week Range

Low: €15.14 High: €22.40

on December 23, 2024

on June 6, 2025

All-Time High: €41.80 on August 4, 2014

Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights

Key Statistics

Market Cap i €1.6B

EPS i 1.10

P/E Ratio (TTM) i 19.91

Forward P/E i 16.59

P/B Ratio i 3.18

PEG Ratio i 16.59

Div. Yield i 1.59%

ROE i 16.65%

Beta i 0.244

Debt to Equity i 76.53

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 14.98%

Profit Margin i 9.24%

Returns and Earnings

Return on Assets (TTM) i 7.77%

Return on Equity (TTM) i 16.65%

EBITDA i €164.0M

Net Income (TTM) i €80.6M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i €0.35

Estimated Dividend Yield i 1.59%

5 Year Average Dividend Yield i 1.22%

Last 12-Month Dividend Yield i 1.59%

Last 12-Month Dividend i €0.35

% of Earnings Paid as Dividends i 27.27%

Dividend Date i N/A

Ex-Dividend Date i May 19, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Fagron NV FAGR	1.60B Large-cap	-0.23%	2.58%	13.92%	18.88%	30.37%	23.59%	35.27%	12.31%
Argenx SE ARGX	30.72B Large-cap	-5.90%	-4.22%	-13.76%	-20.25%	-20.91%	39.26%	51.84%	157.48%
Solvac S.A SOLV	1.87B Large-cap	0.00%	1.14%	-7.87%	-13.17%	-10.28%	-20.55%	-7.02%	-8.19%
Ion Beam IBAB	363.48M Mid-cap	-3.69%	5.45%	-6.25%	-8.95%	-12.02%	-8.53%	-17.43%	55.67%
Nyxoah S.A NYXH	252.65M Mid-cap	-2.87%	18.56%	-30.21%	-12.76%	-21.28%	-7.79%	-36.92%	-65.38%
Onward Medical N.V ONWD	186.17M Mid-cap	-3.00%	1.45%	-12.50%	-13.22%	-21.35%	-13.31%	-24.46%	-67.27%

Ownership & Short Interest

Insider Ownership i 5.13%

Institutional Ownership i 66.69%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 54K

Average 90-Day Volume i 56K

Fagron NV Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Fagron NV would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is FAGR's 52-week high and low?

In the last 52 weeks, Fagron NV reached a high of €22.40 (on June 6, 2025) and a low of €15.14 (on December 23, 2024).

What is the market cap and P/E ratio for FAGR?

Curious about Fagron NV's size and valuation? Its market capitalization stands at 1.60B. When it comes to valuation, the P/E ratio (trailing twelve months) is 19.91, and the forward P/E (looking ahead) is 16.59.

Does FAGR pay dividends? If so, what's the yield?

Yes, Fagron NV is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.59%, and the company is expected to pay out €0.35 per share over the coming year.

Who are Fagron NV's main competitors or similar companies to consider before investing?

When looking at Fagron NV, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Argenx SE ARGX	30.72B	Healthcare	Biotechnology	39.26%	51.84%
Solvac S.A SOLV	1.87B	Healthcare	Medical Instruments & Supplies	-20.55%	-7.02%
Ion Beam IBAB	363.48M	Healthcare	Medical Devices	-8.53%	-17.43%
Nyxoah S.A NYXH	252.65M	Healthcare	Medical Instruments & Supplies	-7.79%	-36.92%
Onward Medical N.V ONWD	186.17M	Healthcare	Biotechnology	-13.31%	-24.46%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Fagron NV? (e.g., ROE, Debt/Equity)

To get a sense of Fagron NV's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.65%, the Debt to Equity ratio from the most recent quarter is 76.53, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for FAGR?

Looking at Fagron NV's growth, its revenue over the trailing twelve months (TTM) was €872M. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.10%, and quarterly earnings saw a YoY growth of 7.00%.

How much of FAGR stock is held by insiders and institutions?

Wondering who owns Fagron NV stock? Company insiders (like executives and directors) hold about 5.13% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 66.69%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.